Literature DB >> 6713337

Pentazocine-induced agranulocytosis.

H Haibach, Y W Yesus, J J Doggett.   

Abstract

A 46-year-old man with pentazocine-induced agranulocytosis is described. In previously reported cases of a complete absence of mature neutrophils in the peripheral blood and bone marrow the patients had undergone marrow-depressing treatment with radiation and antineoplastic drugs. This case is unique in that the patient had complete agranulocytosis without predisposing factors.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6713337      PMCID: PMC1876036     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  6 in total

Review 1.  Pentazocine: a review of its pharmacological properties, therapeutic efficacy and dependence liability.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1973       Impact factor: 9.546

2.  Fatal pancytopenia after administration of Fortagestic.

Authors:  S B Datta
Journal:  Br Med J       Date:  1973-07-21

3.  Granulocytopenia after intravenous abuse of pentazocine and tripelennamine ("Ts and blues").

Authors:  R M Heaney; N Gotlieb
Journal:  South Med J       Date:  1983-05       Impact factor: 0.954

4.  Pentazocine and agranulocytosis.

Authors:  A Marks; N Abramson
Journal:  Ann Intern Med       Date:  1980-03       Impact factor: 25.391

Review 5.  Drug-induced agranulocytosis.

Authors:  V Pisciotta
Journal:  Drugs       Date:  1978-02       Impact factor: 9.546

6.  Agranulocytosis secondary to pentazocine therapy.

Authors:  E C Hoppin; B R Greenberg; R M Walter
Journal:  Arch Intern Med       Date:  1978-04
  6 in total
  1 in total

1.  Pentazocine-induced agranulocytosis.

Authors:  M Sheehan; R H Hyland; C Norman
Journal:  Can Med Assoc J       Date:  1985-06-15       Impact factor: 8.262

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.